PML enhances the regulation of p53 by CK1 in response to DNA damage

O Alsheich-Bartok1, S Haupt, I Alkalay-Snir

  • 1Department of Immunology, The Hebrew University Hadassah Medical School, Jerusalem, Israel.

Oncogene
|February 5, 2008
PubMed

Insights

Promyelocytic leukemia protein (PML) enhances stress-induced p53 phosphorylation at Thr18 by recruiting casein kinase 1 (CK1). This action protects p53 from Mdm2 degradation, promoting its activation.

Area of Science:

  • Molecular Biology
  • Cellular Biology
  • Cancer Research

Background:

  • Stress and DNA damage trigger p53 accumulation and activation for growth inhibition.
  • p53 activity is regulated by negative regulators Mdm2 and Mdm4.
  • Phosphorylation of p53 at Thr18 is crucial for releasing it from Mdm2/4 inhibition.

Purpose of the Study:

  • To investigate the role of promyelocytic leukemia protein (PML) in regulating p53 Thr18 phosphorylation.
  • To elucidate the mechanism by which PML influences p53 regulation by casein kinase 1 (CK1).

Main Methods:

  • Studied endogenous p53 phosphorylation at Thr18 in response to stress.
  • Assessed the localization and interaction of p53, PML, and CK1 following DNA damage.
  • Utilized CK1 inhibition to evaluate its impact on PML-mediated p53 protection.

Main Results:

  • PML enhances endogenous p53 Thr18 phosphorylation under stress conditions.
  • DNA damage induces nuclear accumulation and interaction of CK1 with p53 and PML.
  • CK1 inhibition disrupts PML's protective effect on p53 against Mdm2-mediated degradation.

Conclusions:

  • PML plays a significant role in regulating p53 phosphorylation by CK1.
  • PML facilitates p53 activation by recruiting p53 and CK1 to PML nuclear bodies, preventing Mdm2 inhibition.

Related Concept Videos

Abnormal Proliferation02:23

Abnormal Proliferation

Under normal conditions, most adult cells remain in a non-proliferative state unless stimulated by internal or external factors to replace lost cells. Abnormal cell proliferation is a condition in which the cell's growth exceeds and is uncoordinated with normal cells. In such situations, cell division persists in the same excessive manner even after cessation of the stimuli, leading to persistent tumors. The tumor arises from the damaged cells that replicate to pass the damage to the daughter...
DNA Damage Can Stall the Cell Cycle02:36

DNA Damage Can Stall the Cell Cycle

In response to DNA damage, cells can pause the cell cycle to assess and repair the breaks. However, the cell must check the DNA at certain critical stages during the cell cycle. If the cell cycle pauses before DNA replication, the cells will contain twice the amount of DNA. On the other hand, if cells arrest after DNA replication but before mitosis, they will contain four times the normal amount of DNA. With a host of specialized proteins at their disposal,cells must use the right protein at...
DNA Damage can Stall the Cell Cycle02:36

DNA Damage can Stall the Cell Cycle

In response to DNA damage, cells can pause the cell cycle to assess and repair the breaks. However, the cell must check the DNA at certain critical stages during the cell cycle. If the cell cycle pauses before DNA replication, the cells will contain twice the amount of DNA. On the other hand, if cells arrest after DNA replication but before mitosis, they will contain four times the normal amount of DNA. With a host of specialized proteins at their disposal,cells must use the right protein at...
Negative Regulator Molecules01:23

Negative Regulator Molecules

Positive regulators allow a cell to advance through cell cycle checkpoints. Negative regulators have an equally important role as they terminate a cell’s progression through the cell cycle—or pause it—until the cell meets specific criteria.
Inhibition of Cdk Activity02:34

Inhibition of Cdk Activity

The orderly progression of the cell cycle depends on the activation of Cdk protein by binding to its cyclin partner. However, the cell cycle must be restricted when undergoing abnormal changes. Most cancers correlate to the deregulated cell cycle, and since Cdks are a central component of the cell cycle, Cdk inhibitors are extensively studied to develop anticancer agents. For instance, cyclin D associates with several Cdks, such as Cdk 4/6, to form an active complex. The cyclin D-Cdk4/6 complex...
Interactions Between Signaling Pathways01:19

Interactions Between Signaling Pathways

Signaling cascades usually lack linearity. Multiple pathways interact and regulate one another, allowing cells to integrate and respond to diverse environmental stimuli.
Convergence and divergence, and cross-talk between signaling pathways
Two distinct signaling pathways can converge on a single functional unit, which may either be a single protein or a complex of proteins. The response is either functionally distinct or synergistic between the two pathways but different from the response...